BioLineRx Ltd. (NASDAQ: BLRX) announced today that data on BL-8040, the Company's leading oncology platform, have been accepted for presentations ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE